{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260618126844/en/Enanta-Pharmaceuticals-Announces-Advancement-of-its-Zelicapavir-Clinical-Development-Program-for-the-Treatment-of-Respiratory-Syncytial-Virus-RSV", "message": "News view counter 806871 successfully enlarged"}